1,148
Views
33
CrossRef citations to date
0
Altmetric
Research Article

Chitosan-N-Acetyl Cysteine Conjugates: In Vitro Evaluation of Permeation Enhancing and P-Glycoprotein Inhibiting Properties

, &
Pages 245-252 | Received 22 Oct 2007, Accepted 29 Nov 2007, Published online: 10 Oct 2008

REFERENCES

  • Bernkop-Schnürch A., Kast C. E., Guggi D. Permeation enhancing polymers in oral delivery of hydrophilic macromolecules: thiomer/GSH systems. J. Control. Release 2003; 93: 95–103
  • Bernkop-Schnürch A., Hornof M., Guggi D. Thiolated chitosans. Eur. J. Pharm. Biopharm. 2004; 57: 9–17
  • Clausen A. E., Kast C. E., Bernkop-Schnürch A. The role of glutathione in the permeation enhancing effect of thiolated polymers. Pharm. Res. 2002; 19: 602–608
  • D'Emanuele A., Jevprasesphant R., Penny J., Attwood D. The use of a dendrimer-propranolol prodrug to bypass efflux transporters and enhance oral bioavailability (vol 95 pg 447 2004). J. Control. Release 2004; 96: 513–513
  • Decker T., Lohmannmatthes M. L. A Quick and simple method for the quantitation of lactate-dehydrogenase release in measurements of cellular cyto-toxicity and tumor necrosis factor (Tnf) activity. J. Immunol. Methods 1988; 115: 61–69
  • Demeule M., Brossard M., Turcotte S., Regina A., Jodoin J., Beliveau R. Diallyl disulfide, a chemopreventive agent in garlic, induces multidrug resistance-associated protein 2 expression. Biochem. Biophys. Res. Commun. 2004; 324: 937–945
  • Föger F., Schmitz T., Bernkop-Schnürch A. In vivo evaluation of an oral delivery system for P-gp substrates based on thiolated chitosan. Biomaterials 2006; 27: 4250–4255
  • Guggi D., Bernkop-Schnürch A. Improved paracellular uptake by the combination of different types of permeation enhancers. Int. J. Pharm. 2005; 288: 141–150
  • Ho G. T., Moodie F. M., Satsangi J. Multidrug resistance 1 gene (P-glycoprotein 170): an important determinant in gastrointestinal disease?. Gut 2003; 52: 759–766
  • Hugger E. D., Novak B. L., Burton P. S., Audus K. L., Borchardt R. T. A comparison of commonly used polyethoxylated pharmaceutical excipients on their ability to inhibit P-glycoprotein activity in vitro. J. Pharm. Sci. 2002; 91: 1991–2002
  • Imam M. E., Hornof M., Valenta C., Reznicek G., Bernkop-Schnürch A. Evidence for the interpenetration of mucoadhesive polymers into the mucus gel layer. S. T. P. Pharma Sci. 2003; 13: 171–176
  • Kabanov A. V., Batrakova E. V., Alakhov V. Y. Pluronic block copolymers for overcoming drug resistance in cancer. Adv. Drug Deliv. Rev. 2002; 54: 759–779
  • Legrand C., Bour J. M., Jacob C., Capiaoumont J., Martial A., Marc A., Wudtke M., Kretzmer G., Demangel C., Duval D. Lactate dehydrogenase (LDH) activity of the cultured eukaryotic cells as marker of the number of dead cells in the medium [corrected]. J. Biotechnol. 1992; 25: 231–243
  • Liu R., Sharom F. J. Site-directed fluorescence labeling of P-glycoprotein on cysteine residues in the nucleotide binding domains. Biochemistry 1996; 35: 11865–11873
  • Loo T. W., Clarke D. M. Drug-stimulated ATPase activity of human P-glycoprotein is blocked by disulfide cross-linking between the nucleotide-binding sites. J. Biol. Chem. 2000; 275: 19435–19438
  • Loo T. W., Clarke D. M. Blockage of drug resistance in vitro by disulfiram, a drug used to treat alcoholism. J. Natl. Cancer Inst. 2000; 92: 898–902
  • Loo T. W., Bartlett M. C., Clarke D. M. Substrate-induced conformational, changes in the transmembrane segments of human P-glycoprotein-Direct evidence for the substrate-induced fit mechanism for drug binding. J. Biol. Chem. 2003; 278: 13603–13606
  • Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983; 65: 55–63
  • Ohkubo R., Tomita M., Hotta Y., Nagira M., Hayashi M. Comparative study of flux of FITC-labeled Dextran 4000 on normal (iso)- and hyper-osmolarity in basal side in caco-2 cell monolayers. Drug Metab. Pharmacokinet. 2003; 18: 404–408
  • Regev R., Assaraf Y. G., Eytan G. D. Membrane fluidization by ether, other anesthetics, and certain agents abolishes P-glycoprotein ATPase activity and modulates efflux from multidrug-resistant cells. Eur. J. Biochem. 1999; 259: 18–24
  • Schmitz T., Grabovac V., Palmberger T. F., Hoffer M. H., Bernkop-Schnürch A. Synthesis and characterization of a chitosan-N-acetyl cysteine conjugate. Int. J. Pharm. 2008; 347: 79–85
  • Tomita M., Hotta Y., Ohkubo R., Awazu S. Polarized transport was observed not in hydrophilic compounds but in dextran in Caco-2 cell monolayers. Biol. Pharm. Bull. 1999; 22: 330–331
  • Varma M. V. S., Ashokraj Y., Dey C. S., Panchagnula R. P-glycoprotein inhibitors and their screening: a perspective from bioavailability enhancement. Pharmacol. Res. 2003; 48: 347–359
  • Werle M., Hoffer M. Glutathione and thiolated chitosan inhibit multidrug resistance P-glycoprotein activity in excised small intestine. J. Control. Release 2005; 111: 41–46
  • Zhou X. H., Po A. L. W. Peptide and protein drugs.1. Therapeutic applications, absorption and parenteral administration. Int. J. Pharm. 1991; 75: 97–115

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.